Jeffrey R. Harris

Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition

Jason R. Rock, Christina E. Barkauskas, Michael J. Cronce et al. · Proceedings of the National Academy of Sciences · 2011 · 1K citations

Developing an evidence-based guide to community preventive services—methods11Some of this material has been previously published in: Shefer A, Briss P, Rodewald L, et al. Improving immunization coverage rates: An evidence-based review of the literature. Epidemiologic Reviews 1999;20:96–142.22The names and affiliations of the Task Force members are listed on page v of this supplement and at http://www.thecommunityguide.org

Peter A. Briss, Stephanie Zaza, Marguerite Pappaioanou et al. · American Journal of Preventive Medicine · 2000 · 569 citations

Population Health Sciences, Vaccine Hesitancy, Immunization Coverage Rates +20

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens et al. · The Lancet Oncology · 2021 · 367 citations

Tisotumab Vedotin, Cervical Cancer, Metastatic Cervical Cancer +8

FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH

JohnD Clemens, Jeffrey R. Harris, M. R. Khan et al. · The Lancet · 1986 · 359 citations

Vaccination, Mucosal Vaccination, Infection Control +2

Priorities among recommended clinical preventive services11The full text of this article is available via AJPM Online at www.elsevier.com/locate/ajpmonline.

Ashley B. Coffield, Michael V. Maciosek, J. Michael McGinnis et al. · American Journal of Preventive Medicine · 2001 · 352 citations · Full text

Primary Care, Preventive Medicine, Health Policy +10